Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Amphera

Cell and Gene Therapy, Clinical Trials, Industry, Research and Development

Positive results for Amphera’s MesoPher cell therapy

December 12, 2022

Via: Pharma Times

Amphera – a company developing MesoPher cell therapy to treat cancer – has delivered positive results from its phase 2 Reactive trial and phase 2/3 DENIM trial. During the phase 2 Reactive study, patients with resected pancreatic cancer who had […]